Antioxidant Potential, Acute Toxicity Profile and Bioavailability Studies of Water Soluble Analogue of Curcumin

Dr. Mohammad Haneef; Mr. Viney Budhiraja and Mr. Paras Budhiraja

1. Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19(12):20091-112. doi: 10.3390/molecules191220091, PMID 25470276.

2. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195-218. doi: 10.1208/s12248-012-9432-8, PMID 23143785.

3. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A):363-98. PMID 12680238.

4. Lestari ML, Indrayanto G. Curcumin. Profiles Drug Subst Excip Relat Methodol. 2014;39:113-204. doi: 10.1016/B978-0-12-800173-8.00003-9, PMID 24794906.

5. Mahady GB, Pendland SL, Yun G, Lu ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2002;22(6C):4179-81. PMID 12553052.

6. Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326(2):472-4. doi: 10.1016/j.bbrc.2004.11.051, PMID 15582601.

7. Vera-Ramirez L, Pérez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. BioFactors. 2013;39(1):88-100. doi: 10.1002/biof.1057, PMID 23303639.

8. Wright LE, Frye JB, Gorti B, Timmermann BN, Funk JL. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Curr Pharm Des. 2013;19(34):6218-25. doi: 10.2174/1381612811319340013, PMID 23448448.

9. Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16(6):4567-98. doi: 10.3390/molecules16064567, PMID 21642934.

10. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10. doi: 10.1186/1472-6882-6-10, PMID 16545122.

11. Malik SN, Canaham DH, Gouda MW. Effect of surfactants on absorption through membranes III: Effects of dioctyl sodium sulfosuccinate and poloxalene on absorption of a poorly absorbable drug, phenolsulfonphthalein, in rats. J Pharm Sci. 1975;64(6):987-90. doi: 10.1002/jps.2600640620, PMID 1133757.

12. Reddy RK, Khalil SA, Gouda MW. Effect of dioctyl sodium sulfosuccinate and poloxamer 188 on dissolution and intestinal absorption of sulfadiazine and sulfisoxazole in rats. J Pharm Sci. 1976;65(1):115-8. doi: 10.1002/jps.2600650126, PMID 1255414.

13. El-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm. 2006;32(2):141-50. doi: 10.1080/03639040500465983, PMID 16537195.

14. Frizon F, Eloy JdO, Donaduzzi CM, Mitsui ML, Marchetti JM. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technol. 2013;235:532-9. doi: 10.1016/j.powtec.2012.10.019.

15. Shelat DY, Acharya SR. Cur-Ca-Thione: A Novel curcumin concoction with enhanced water solubility and Brain Bio-Availability. Int J Pharm Pharm Sci;8(12):265-70. doi: 10.22159/ijpps.2016v8i12.15093.

16. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-18. doi: 10.1021/mp700113r, PMID 17999464.

17. Shelat P, Mandowara V, Gupta D, Patel S. Formulation of curcuminoid loaded solid lipid nanoparticles in order to improve oral bioavailability. Int J Pharm Pharm Sci. 2015;7:7-11.

18. Leung MH, Kee TW. Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir. 2009;25(10):5773-7. doi: 10.1021/la804215v, PMID 19320475.

19. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 1997;15(12):1867-76. doi: 10.1016/s0731-7085(96)02024-9, PMID 9278892.

20. Kurmi R, Mishra D, Jain D. Solid dispersion: a novel means of solubility enhancement. Crit Rev. 2016;3:1-8.

21. OECD guideline for testing of chemicals, Test No. 423. Acute oral toxicity- acute toxic class method; adopted on 17th December, 2001.

22. United Nations. Globally harmonised system of classification and labelling of chemicals (GHS). 7th rev ed. Geneva and New York; 2017.

23. Compendium of Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). J Clim Change. 2018.

24. Shankar TN, Shantha NV, Ramesh HP, Murthy IA, Murthy VS Bhavani et al. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. Indian J Exp Biol. 1980;18(1):73-5. PMID 6772551.

25. Aggarwal ML, Chacko KM, Kuruvilla BT. Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation. Mol Med Rep. 2016;13(1):592-604. doi: 10.3892/mmr.2015.4579, PMID 26648561.

26. Gopi S, Jacob J, Mathur KY. Acute and subchronic oral toxicity studies of hydrogenated curcuminoid formulation ’CuroWhite’ in rats. Toxicol Rep. 2016;3:817-25. doi: 10.1016/j.toxrep.2016.10.007, PMID 28959609.

27. Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci. 2010;5(1):49-56. PMID 21589768.

28. Ghumre, Priti B., Sujata S. Bote, Shweta R. Kotgir, Apeksha B. Korde, Bhagyashri S. Bhosale, and Rahul B. Chaudhari. "SOLUBILITY ENHANCEMENT TECHNIQUE–A REVIEW." (2021).